Search for: "BRISTOL-MYERS SQUIBB COMPANY" Results 161 - 180 of 468
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Aug 2016, 5:45 am by Adam Steinman
Yesterday the California Supreme Court issued a 4-to-3 decision in Bristol-Myers Squibb Company v. [read post]
22 Aug 2016, 12:53 pm by Tom Lamb
To overcome that headwind and broaden the use of their drugs, Johnson & Johnson, Bristol-Myers Squibb, and Pfizer provided funding to Portola Pharmaceuticals so it could develop AndexXa. [read post]
10 Aug 2016, 5:23 pm by Kevin LaCroix
On August 5, 2016, a shareholder filed a derivative lawsuit in New York (New York County) Supreme Court against Bristol-Myers Squibb, as nominal defendant, and the company’s board of directors. [read post]
10 Aug 2016, 2:40 pm by Michael Grossman
Created by the Japanese company Otsuka Pharmaceutical, it is marketed in North America by Otsuka America and their partner company Bristol Myers-Squibb, an enormous biopharmaceutical manufacturer/marketer. [read post]
4 Aug 2016, 9:24 am by Neumann Law Group
It is Bristol-Myers Squibb’s top-selling drug; it earned the pharmaceutical company $6.4 billion in 2013. [read post]
30 Jun 2016, 12:12 pm by Tom Lamb
More recently, Eliquis lawsuits have started to be filed against Bristol-Myers Squibb and Pfizer, with some accusing these pharmaceutical companies of touting Eliquis as safe and effective, while hiding or obscuring the risk of serious bleeding events and failing to sufficiently warn that there is no antidote to the anticoagulant effect of Eliquis. [read post]
10 May 2016, 3:02 pm by Dr. Shezad Malik
One of the most popular treatment for a variety of mental disorders like bipolar disorder, schizophrenia, and depression, Abilify makes billions for Otsuka Pharmaceutical Company and Bristol-Myers Squibb. [read post]
21 Apr 2016, 7:35 am by Devika Agarwal
The first application pertained to Bristol-Myers Squibb’s cancer drug, Dastanib, which was filed by Indian generic drug manufacturer, BDR Pharma. [read post]
12 Apr 2016, 10:57 am by Dr. Shezad Malik
Nicholas Meyer recently filed against Bristol-Myers Squibb and Otsuka Pharmaceutical Co. in the U.S. [read post]
8 Mar 2016, 8:01 am by Dr. Shezad Malik
Nicholas Meyer recently filed against Bristol-Myers Squibb and Otsuka Pharmaceutical Co. in the U.S. [read post]
15 Feb 2016, 5:56 am by Law Offices of Jeffrey S. Glassman
According to a recent news feature from Fierce Pharma, Bristol-Myers Squibb (BMY) has reported huge profits over the past fiscal quarter. [read post]
10 Nov 2015, 11:33 am by Tom Lamb
Reporting at the American Heart Association 2015 Scientific Sessions in Orlando, FL, a team of drug company researchers offered results of a retrospective cohort study showing that apixaban (Eliquis/Bristol-Myers-Squibb/Pfizer) had a lower risk of bleeding.... [read post]
10 Nov 2015, 3:41 am by Broc Romanek
Don’t forget to tune in today for the webcast – “How to Draft Meaningful Sustainability Reports” – to hear Lou Coppola of the Governance & Accountability Institute, Kate Kelly of Bristol-Myers Squibb and Pam Styles of Next Level Investor Relations explain the keys to drafting sustainability reports that are meaningful to investors & other constituents and a “how to” list of things you should be aware of when drafting. [read post]
9 Nov 2015, 7:39 am
BackgroundOno owns a patent relating to immunotherapy -- specifically the use of anti-PD-1 antibodies for treating cancer (and Bristol-Myers Squibb is the exclusive licensee). [read post]
9 Nov 2015, 3:55 am by Broc Romanek
Would be used much more than XBRL…” Webcast: “How to Draft Meaningful Sustainability Reports” Tune in tomorrow for the webcast – “How to Draft Meaningful Sustainability Reports” – to hear Lou Coppola of the Governance & Accountability Institute, Kate Kelly of Bristol-Myers Squibb and Pam Styles of Next Level Investor Relations explain the keys to drafting sustainability reports that are meaningful to investors &… [read post]
2 Nov 2015, 7:42 am by Altman & Altman
Its joint manufacturers, Pfizer and Bristol-Myers Squibb, have recently kicked off a targeted direct-to-consumer advertising campaign to market the drug for a-fib treatment as well as for newly approved uses. [read post]
26 Oct 2015, 8:05 am by SEClaw Staff
Two Grant Thornton Firms With Violating Auditor Independence RulesGrant Thornton India LLP and Australia-based Grant Thornton Audit Pty Limited have been charged with auditor independence violations that occurred when two Grant Thornton Mauritius partners served on the boards of Mauritius-based subsidiaries of companies that were Grant Thornton audit clients and performed non-audit services prohibited under the SEC’s auditor independence rules.New Jersey Fund Manager Charged With… [read post]